84.22.Z - Defence activities
71.2 - Technical testing and analysis
72.1 - Research and experimental development on natural sciences and engineering
72.2 - Research and experimental development on social sciences and humanities
74 - Other professional, scientific and technical activities
84.22 - Defence activities
86.1 - Hospital activities
86.2 - Medical and dental practice activities
86.9 - Other human health activities
96.09 - Other personal service activities not elsewhere classified
2019 | 2020 | 2021 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Net sales | 50,6 | 51,9 | 55,6 | 7,1 |
Liabilities and provisions | 68,2 | 73 | 73,8 | 1,2 |
Equity | 68,2 | 71,3 | 74,2 | 4,1 |
Total assets | 136,3 | 144,3 | 148,1 | 2,6 |
Cash and cash equivalents | 11,4 | 14,3 | 14,1 | -1,5 |
Depreciation | 5,6 | 9,1 | 5,9 | -34,4 |
Gross profit / loss | 3 | 3,3 | 3,6 | 9,6 |
EBITDA | 8,6 | 12,4 | 9,6 | -22,4 |
Net profit / loss | 2,9 | 3,2 | 3,3 | 2,8 |
Operating profit (EBIT) | 3 | 3,3 | 3,6 | 10,8 |
Current assets | 15,9 | 22,2 | 23,2 | 4,6 |
% | % | % | p.p. | |
Return on equity (ROE) | 4,3 | 4,5 | 4,4 | -0,1 |
Return on sales (ROS) | 5,8 | 6,2 | 5,9 | -0,3 |
Equity ratio | 50 | 49,4 | 50,1 | 0,7 |
EBITDA margin | 17 | 23,8 | 17,3 | -6,5 |
Gross profit margin | 6 | 6,4 | 6,5 | 0,1 |
Days | Days | Days | Days | |
Current liabilities turnover ratio | 27 | 55 | 38 | -17 |
Current ratio | 0,3 | 0,3 | 0,3 | 0 |
Net debt to EBITDA | -1,3 | -1,2 | -1,5 | -0,3 |
Opinions regarding services, products, and company activities are not verified. This means that ING Services for Business S.A., as the provider of the Aleo platform, does not ensure that the published opinions come from consumers who have used the product or availed of the company's services. However, we do strive to ensure that opinions do not violate universally applicable laws.